INTERNATIONAL PATENT: AMICUS THERAPEUTICS, INC. FILES APPLICATION FOR "MIGLUSTAT FORMULATIONS COMPRISING NITROSAMINE FOR USE IN THE TREATMENT OF POMPE DISEASE"

GENEVA, Jan. 7 -- AMICUS THERAPEUTICS, INC. (3675 Market StreetPhiladelphia, Pennsylvania 19104) filed a patent application (PCT/US2025/035523) for "MIGLUSTAT FORMULATIONS COMPRISING NITROSAMINE FOR USE IN THE TREATMENT OF POMPE DISEASE" on Jun 26, 2025. With publication no. WO/2026/006625, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHEIKH, Mohammed Sheikh (3675 Market StreetPhiladelphia, Pennsylvania 19104)

Abstract: Provided are compositions comprising certain miglustat-related nitrosamine compounds, such as pharm...